Carboplatin-Pemetrexed in Treatment of Patients with Recurrent/Metastatic Cancers of the Head and Neck; Superior Outcomes in Oropharyngeal Primaries

Background: Platinum-based therapy in combination with 5-fluorouracil with cetuximab has shown the best survival in pts with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). The purpose of this study is to evaluate the efficacy and tolerability of carboplatin, pemetrexe...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhotra, Binu, Bellile, Emily Light, Nguyen, Nghia Pham Trung, Fung, Vicki Kay, Slack, Matthew, Bilich, Rebecca, Papagerakis, Silvana, Worden, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306299/
https://www.ncbi.nlm.nih.gov/pubmed/25674535
http://dx.doi.org/10.3389/fonc.2014.00362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306299/
https://www.ncbi.nlm.nih.gov/pubmed/25674535
http://dx.doi.org/10.3389/fonc.2014.00362

Ejemplares similares